Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

First Line Chemotherapy for Advanced NSCLC: An Introduction
Author
Howard (Jack) West, MD

This pilot video slide presentation covers the development of our current standards for first line chemotherapy to treat advanced non-small cell lung cancer.

[powerpress]

These series will be called GRACEcasts (love it?), and we're in the process of developing a bunch of audio interviews with experts for an audio channel, and multiple video presentations, which are going to be about 10 minutes each, just little chapters at one time.

And you don't need to worry about getting all of the information in one viewing, because we'll plan to upload a copy of the slides and a transcript of the narration that you can download and review anytime.

Adv NSCLC First Line Chemo Slide Set

Adv NSCLC First Line Chemo Transcript

Where to next? Here's a list of some planned video GRACEcasts for the coming months:

Intro to SCLC
Limited SCLC
First Line Treatment of SCLC
Relapsed SCLC
General principles of Adjuvant Therapy for Resected NSCLC
Adjuvant Chemo for Stage I NSCLC
Management Options for Stage IIIA NSCLC
Optimal Treatment of Unresectable Locally Adv NSCLC
Angiogenesis for First Line Treatment of Adv NSCLC
EGFR-Based Therapy for Advanced NSCLC
Second Line Chemo for Adv NSCLC
Timing Therapy in Adv NSCLC: The Evolving Role of Maintenance Therapy
Rash/toxicity Management with EGFR Inhibitors
Histology Matters: Tailoring therapy by Histology for NSCLC
Molecular markers for EGFR-based Therapy
Treatment of Poor risk/elderly pts with Adv NSCLC
Combinations of Targeted Therapies
Multi-Targeted Therapies

Got ideas for more topics? We're open to suggestions. And we'd also be eternally grateful for sponsorhip of one of these key presentations, a great way to show your support for the cancer community. Just e-mail us at info@cancergrace.org.

We hope you like our transition into audio and video.

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on